纳金因酸性脂质修饰纳米颗粒通过调节脂质稳态和肠道微生物群来缓解MASLD的进展
Lu Dong1, Wenyong Lou1, Congfei Xu2
1School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong Province, 510641, China.
Journal of nanobiotechnology
|March 4, 2025
概括
装有纳灵宁 (NP-NAR) 的阴离子纳米颗粒有效地治疗小鼠的代谢功能障碍相关的脂肪性肝病 (MASLD). NP-NAR通过调节脂质代谢,减少炎症和恢复肠道微生物群平衡来改善肝脏健康.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 纳米医学是一种纳米医学.
背景情况:
- 纳灵宁 (NAR) 具有抗氧化,抗炎和肝脏保护性质.
- 由于其溶解性差和晶体结构差,NAR的治疗用途受到阻碍.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题,治疗选择有限.
研究的目的:
- 评估纳灵载纳米粒子 (NP-NAR) 对MASLD的治疗潜力.
- 在MASLD小鼠模型中阐明NP-NAR有效性的基础分子机制.
主要方法:
- NP-NAR的制定和描述.
- 在小鼠模型中诱导MASLD.
- 评估肝功能,脂质代谢,氧化应激,胰岛素抵抗和炎症.
- 转录基因分析和分子途径调查 (PPAR信号传递,脂质生成,胆固醇代谢).
- 使用16S rDNA基因测序进行肠道微生物群分析.
主要成果:
- 在MASLD小鼠中,NP-NAR显著改善了脂质代谢障碍,氧化应激,胰岛素抵抗和炎症.
- 通过PPAR路径激活,NP-NAR促进了脂肪酸氧化.
- 通过抑制CD36,ACC和FASN基因表达,NP-NAR减少了肝脏脂质的吸收和脂质生成.
- NP-NAR通过抑制胆汁酸合成来调节胆固醇代谢.
- 通过NP-NAR治疗,可以逆转肠道微生物群的失调,并恢复短链脂肪酸的产生.
结论:
- NP-NAR证明了对MASLD的显著治疗潜力.
- NP-NAR通过多种机制起作用,包括调节脂质代谢,减少炎症和调节肠道微生物群.
- NP-NAR为治疗与肥胖相关的MASLD提供了一个有希望的策略.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Lipid Catabolism
1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K


